why choose us

First received: November 4, 2022

Clinical Trial: Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia

Study Status: Completed

Recruit Status: Completed

Condition: Hereditary Spastic Paraplegia

Study Type: Interventional


Official Title: Effect of Dalfampridine in Patients With Hereditary Spastic Paraplegia

Brief Summary: There are limited but encouraging results supporting the use of dalfampridine in patients with hereditary spastic paraplegia. The investigators aimed to investigate the effects of dalfampridine on walking speed, muscle length, spasticity, functional strength, and functional mobility in patients with hereditary spastic paraplegia. In this triple-blinded, randomized, placebo-controlled trial, 4 patients with hereditary spastic paraplegia received dalfampridine (10 mg twice daily) plus physiotherapy (2 times per…

Read more